OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study

Liam G Heaney, Andrew Menzies-Gow, Mark Gurnell, Jonathan Corren, Elisabeth H Bel, Jorge F Maspero, Timothy Harrison, David Jackson, David Price, Njira Lugogo, James Kreindler, Annie Burden, Alex de Giorgio-Miller, Kelly Padilla, Ubaldo J. Martin, Esther Garcia Gil

Research output: Contribution to conferenceAbstractpeer-review

Abstract

Severe asthma is frequently associated with comorbidities. Nasal polyps (NP), in particular, indicate an eosinophilic phenotype and have been shown to predict an enhanced response to benralizumab in terms of asthma exacerbations and lung function. I
Original languageEnglish
Publication statusAccepted/In press - 12 Mar 2021
EventATS International Conference Committee: ATS 2021 - Virtual event
Duration: 14 May 202119 May 2021
https://conference.thoracic.org/

Conference

ConferenceATS International Conference Committee
Period14/05/2119/05/21
Internet address

Fingerprint Dive into the research topics of 'OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study'. Together they form a unique fingerprint.

Cite this